How many prescriptions did your pharmacy fill last week that never reached a patient? Not because of a clinical issue or an insurance rejection, but because nobody picked them up. That's the will call problem, and it's one of the most quietly expensive workflows in the building.

Where Will Call Breaks Down

Will call is the holding zone between "prescription filled" and "prescription in the patient's hands." The prescription sitting in will call isn't the problem. The problem is everything that has to happen around it — and what it costs when it doesn't.

When a prescription doesn't move, the work compounds:

• Someone has to track which bags have been sitting too long

• Staff have to fit manual follow-up calls into the gaps between fills

• Multiple contacts often go unanswered — voicemails, texts, callbacks

• If a patient declines or goes silent, the pharmacy rarely learns why

• When the return-to-stock window closes, the claim gets reversed and the medication goes back on the shelf

That last point matters more than it looks. By the time a prescription returns to stock, it's already absorbed the cost of every step that went into filling it: the dispense, the adjudication, the verification, the label, the bag. All of that labor is gone. The return-to-stock event erases the work.

And when no one knows why patients are declining or going dark, the same prescriptions keep cycling through the same pattern.

What the Best Pharmacies Do Differently

Pharmacies that keep will call moving tend to share a few practices.

They treat will call follow-up as a structured outbound workflow, not something staff squeeze in between other tasks. They track shelf time as a real metric and know their return-to-stock rate. They reach patients through more than one channel, because a patient who ignores an IVR call might respond to a text, and a patient who misses a text might pick up a live phone call. And increasingly, they collect copay before the patient arrives, which removes one of the biggest friction points at pickup and reduces no-shows.

This is where will call automation starts to make sense, not as a replacement for the shelf, but as a way to handle the outreach, follow-up, and payment collection that determines whether the prescription actually reaches the patient.

How Pharmesol Approaches Will Call

Pharmesol's AI Pharmacy Agent connects to your pharmacy management system and knows when prescriptions move to will call in real time. It handles outbound notifications, follows up on a schedule if there's no response, and reaches patients across phone, text, and email, using language that clearly communicates what's waiting for them and why it matters to pick it up.

When a patient connects, the AI gives specific answers pulled from live prescription data: which medications are ready, what the copay is, when the pharmacy is open. It can collect payment over the phone or via text link before the patient arrives.

Pharmesol is also built to learn from the patterns that show up in your will call queue:

• Timing optimization: The system tracks when patients in your pharmacy actually pick up and schedules outreach accordingly — not just a fixed 48-hour trigger, but contact attempts timed to when they're most likely to respond

• Decline tracking: When a patient says they don't want the prescription, the AI asks why and records the reason systematically. Over time, pharmacies can see patterns — insurance issues, side effect concerns, cost — and address them upstream

• High throughput: Pharmesol handles outbound will call notifications at high volume simultaneously, so a busy fill day doesn't create a backlog of calls your staff has to work through the next morning

For prescriptions approaching the return-to-stock window, Pharmesol escalates outreach and documents every attempt, only flagging staff when a situation actually requires human judgment.

Pharmesol is HIPAA compliant, SOC 2 Type II certified, and built by pharmacists and AI experts who understand will call because they've lived it.

Takeaways

• Will call is one of the most pharmacy-specific workflows in the building. If your outreach process around it is still manual or IVR-only, it's worth examining how much time and revenue it's actually costing you.

• Track your return-to-stock rate and average shelf time. These two numbers tell you whether your will call workflow is working or just existing.

• Reach patients through more than one channel. An automated call alone isn't outreach — real follow-up means trying a second and third channel before giving up.

• Collect payment before pickup. It reduces counter time, reduces no-shows, and gives patients one less reason to delay.

• Find out why patients are declining. A patient who says no is worth understanding. That data can change how you handle the workflow upstream.

See How Pharmesol Handles Will Call

If will call follow-up is eating into your team's day and prescriptions are still aging out on the shelf, we'd like to show you how Pharmesol handles it.

Book a Demo